Genetic findings reported by our group and others showed that de novo missense variants in the KIF2A gene underlie malformations of brain development called pachygyria and microcephaly. Though KIF2A is known as member of the Kinesin-13 family involved in the regulation of microtubule end dynamics through its ATP dependent MT-depolymerase activity, how KIF2A variants lead to brain malformations is still largely unknown. Using cellular and in utero electroporation approaches, we show here that KIF2A disease-causing variants disrupts projection neuron positioning and interneuron migration, as well as progenitors proliferation. Interestingly, further dissection of this latter process revealed that ciliogenesis regulation is also altered during progenitors cell cycle. Altogether, our data suggest that deregulation of the coupling between ciliogenesis and cell cycle might contribute to the pathogenesis of KIF2A-related brain malformations. They also raise the issue whether ciliogenesis defects are a hallmark of other brain malformations, such as those related to tubulins and MTmotor proteins variants. † These authors contributed equally.
Introduction
The formation of the complex architecture of the mammalian cortex relies on coordinated developmental processes beginning with an intense phase of progenitor's proliferation in the ventricular zone (VZ). Following this initial phase, waves of committed post mitotic cells exit the cell cycle to undergo an active phase of migration. Excitatory projection neurons originate from the VZ and subventricular zone (SVZ) and migrate radially along the radial glia fibers throughout the cortical wall to reach their final destination forming the laminar cortex. Neurons finally differentiate and acquire identities to establish cortical connectivity by axonal and dendritic extensions.
In humans, alterations in one of these processes can lead to neurodevelopmental disorders including malformations of cortical development (MCD) that represent frequent causes of intellectual disability, psychomotor delay and severe epilepsy (1) .
Among the genetic causes involved in MCD disorders, the predominance of genes encoding microtubule (MT)-related proteins is increasingly convincing. For example, mutations in LIS1 and DCX, both of which encode proteins involved in MT homeostasis, are associated with a large spectrum of neuronal migration disorders encompassing agyria, pachygyria and laminar heterotopias (2) (3) (4) (5) . In addition to DCX and LIS1 genes, the importance of MTs in the development of the cortex is reflected in the finding that mutations in various tubulin genes, including atubulin TUBA1A, b-tubulin TUBB2B, TUBB3 and TUBB and c-tubulin TUBG1, cause a range of MCD syndromes, now referred to as the tubulinopathies (6) (7) (8) (9) (10) (11) . These tubulin-related cortical dysgeneses are thought to involve a combination of abnormal neuronal proliferation, migration, differentiation and axonal growth (7, 9, 10, (12) (13) (14) . More recently, we have reported through whole-exome sequencing, mutations in genes encoding MTdependent motor proteins DYNC1H1, KIF5C and KIF2A in a wide range of cortical and gyral pattern abnormalities associated with microcephaly, reinforcing the idea that MT-dependent mitotic and post-mitotic processes are major contributors to the pathogenesis of MCD (10) .
As far as KIF2A is concerned, several missense variants (c.950G > A, p.Ser317Asn; c.959C > T, p.Thr320Ile; c.961C > G, p.His321Asp and c.962A > C, p.His321Pro) located in the motor domain of KIF2A were identified as being causative of MCD (Supplementary Material, Fig. S2A ). Individuals presented with cortical gyration abnormalities and microcephaly (10, 15, 16) , highlighting the crucial role of KIF2A during cortical development.
KIF2A belongs to the Kinesin-13 family which regulates MT end dynamics through its ATP dependent MT-depolymerase activity (17, 18) . Kinesin-13 proteins are largely described for their critical roles during the cell cycle (19) . KIF2A was shown to be localized at spindle poles to control bipolar spindle assembly and anaphase chromosome movements by destabilizing minus-end MTs (20) (21) (22) (23) (24) . In addition to its role in regulation of the mitotic process, KIF2A is also implicated in various functions in the nervous system. KIF2A is enriched in developing neurons and predominantly accumulated in growth cones where it is required for the regulation of axonal collateral branching, as well as playing a role in axonal pruning (25) (26) (27) . Recently, KIF2A was shown to be a key regulator of primary cilia disassembly through its MT-depolymerizing activity at the mother centriole and this activity is regulated by the mitotic kinase PLK1 that plays a crucial role in the coupling between cilia disassembly and cell proliferation (28) .
In order to better understand pathophysiological mechanisms underlying MCD resulting from KIF2A dysfunction, we investigated the consequences of KIF2A pathogenic variants on cortical development. Here we provide evidence revealing that KIF2A mutants lead to neurodevelopmental defects that combine deregulation of neurogenesis and neuronal migration. Importantly, we showed that KIF2A variants disrupt ciliogenesis and the cell cycle of neuronal progenitors, suggesting the involvement of these two cellular processes in KIF2A-related MCD.
Results

KIF2A is expressed in the developing cerebral cortex
In view of previous observations showing that mutations in KIF2A result in MCD in humans (10, 15, 16) , and keeping in mind that these pathologies are tightly associated with alterations in cortical development (29) , we first examined the expression pattern of the KIF2A protein at different stages of brain corticogenesis in mice. KIF2A was detected throughout the cortical wall at different developmental stages (E14, E16 and E18) with an enrichment in the ventricular zone (VZ) and cortical plate (CP), as shown by immunostainings against the endogenous protein in coronal sections of mouse brains (Supplementary Material, Fig. S1A ), and in agreement with previous observations (30) . This expression remained ubiquitous but became more homogeneous at postnatal day 2 (P2) where a uniform staining throughout the cortex was observed.
We then focused on embryonic day 16, a developmental stage in which there is active cell proliferation and neuronal migration. At this developmental stage, endogenous KIF2A is 
Mutant KIF2A alters cortical neuronal positioning
To investigate the consequences of MCD-related KIF2A variants p.Ser317Asn and p.His321Asp reported by our group (10) (Supplementary Material, Fig. S2A ), we used in utero electroporation to induce the expression of different human KIF2A constructs combined with a Tomato reporter into cortical progenitors of embryonic day 14.5 (E14.5) mouse embryos. First, in line with previously reported data (10), we showed that in utero electroporation of mutant KIF2A constructs leads to an abnormal distribution of mutant proteins in migrating projection neurons (Supplementary Material, Fig. S2B ). Whereas the overexpressed wild type (WT) protein is mainly diffusely dispersed within the cytoplasm, mutant KIF2A localization resembles that of MTs. This mislocalization was also observed in Cos7 cells overexpressing the p.His321Asp variant. While WT KIF2A is dispersed within the cell, without any specific association to MTs, the pathogenic form of KIF2A appears to be sequestered to MTs. The mutant protein heavily co-localizes with tyrosinatedtubulin, and is almost devoided from acetylated-tubulin, suggesting a strong association with dynamic MTs (Supplementary Material, Fig. S2C and D) .
We then studied the consequences of the MCD-related KIF2A mutants initially identified (p.Ser317Asn and p.His321Asp) on neuronal positioning. For this, we analysed the distribution of electroporated projection neurons within the E18.5 cortical wall, four days after in utero electroporation. At this stage, Tomatopositive neurons expressing either of the two KIF2A mutants were mainly clustered in the IZ, with very few neurons migrating towards or reaching the cortical plate (Fig. 1A) . On the other hand, neurons expressing the wild type form of KIF2A were dispersed throughout the cortical wall. Indeed, compared with the control empty vector, the overexpression of wild type KIF2A leads to an accumulation of neurons in the IZ. However, this effect is less severe compared with the mutants which show an almost complete absence of electroporated cells in superficial layers of the developing cortex (Fig. 1A) .
To explore whether the embryonic phenotype persists after birth, we studied the positioning of E14.5 electroporated neurons at P2. As shown in Figure 1B , most of the neurons electroporated with the control empty vector reach the most superficial cortical layers (IV-II, Cux1-positive). As in the control situation, the overexpression of the WT form of KIF2A, leads to an almost complete absence of electroporated cells in the white matter, although there is a small but significantly lower proportion of electroporated cells reaching layers IV-II. These results suggest that the WT KIF2A phenotype is mostly transient as, with time, there is a recovery of the phenotype observed in early stages. In the case of cells expressing mutant KIF2A, abnormally positioned neurons at E18.5 remained arrested in the white matter (WM) at P2 (Fig. 1B) . In this case, over 40% of electroporated neurons accumulate in the WM compared with less than 5% observed in the control. Consistent with this, only 30% of mutant-expressing neurons are located in the Cux1 positive layers. Taken together, these results indicate that KIF2A has a key role in determining neuronal positioning during cortical development, and that both pathogenic KIF2A variants result in a similar phenotype consisting 
Implication of postmitotic processes in the positioning defects
To further understand the mechanisms underlying the ectopic localization of neurons expressing KIF2A constructs, we first focused on the migration of pyramidal neurons. As a strong and consistent phenotype was found for the two mutants, we specifically focused our study on the p.His321Asp variant. We initially controlled the integrity of radial glia, which acts as the scaffold along which post-mitotic neurons migrate, being essential for proper migration (31) . We co-electroporated KIF2A constructs and GFP construct driven by the radial glia specific promoter BLBP (BLBP-GFP), and we observed no evident alteration of glial scaffolding (Supplementary Material, Fig. S3 ). We then focused on the postmitotic effect of the p.His321Asp variant on neuronal positioning. For this, we in utero electroporated at E14.5 constructs that express GFP and the different versions of KIF2A under the neuron-specific Doublecortin (DCX) promoter. At E18.5, the specific expression of both wild type and mutant KIF2A in postmitotic neurons, resulted in an increased fraction of GFP-positive neurons remaining in the IZ with a corresponding depletion of cells reaching the CP (Fig. 2A) . It is worth mentioning that the postmitotic effect of the wild type construct in the distribution of electroporated cells highly resembles that of the overexpression of the protein starting at progenitor stages (Fig. 1A) . However, the mutant construct leads to a less severe phenotype (Fig. 1A) .
In view of the similar phenotype observed for the wild type and mutant overexpression, we focused on the dynamics of the different steps of radial migration to further search for differentially regulated processes between the WT and mutant conditions. For this, we performed time-lapse videomicroscopy acquisitions of DCX-KIF2A expressing neurons in organotypic cultures. Time-lapse acquisitions showed that expression of both WT and mutant constructs affect the initial multipolar to bipolar transition required to start locomotion (Fig. 2B) , the velocity of locomotion of bipolar pyramidal neurons ( Fig. 2C and D) as well as the total duration and number of pauses were significantly affected ( Fig. 2E and F) , leading to an overall delay of radial migration (Fig. 2G ). Though these data suggest that level of expression of KIF2A is critical and migration defects could contribute to the phenotype resulting from KIF2A mutants expression, they do not allow to differentiate between dosage effect and the suspected dominant negative (or gain of function) effect of the MCD-related KIF2A variants.
Mutant KIF2A expression leads to interneuron migration defects
The correct formation of a fully functional cortex requires the timed migration and insertion of interneurons in cortical networks. Cortical interneurons initially migrate through tangential routes, adopting later on a radial mode of migration. Both types of migration depend on cytoskeleton remodeling. To examine the consequences of KIF2A pathogenic variant on interneuron migration and therefore assess the potential contribution of this process in the pathogenicity of KIF2A-related MCD, we performed real-time imaging of electroporated medial ganglionic eminence (MGE) explants cultured on wild type cortical feeders. This in vitro system allowed us to study the effect of KIF2A overexpression in the migration of interneurons, independently from defects in pyramidal neurons. These experiments revealed that, although interneurons were able to migrate out of the explant, cells expressing the mutant form of KIF2A moved significantly slower than the control empty vector or those overexpressing the wild type construct ( Fig. 3A and B) . Additionally, KIF2A variant affected the directionality of this displacement. In the control situation interneurons migrated with a higher persistence of movement, whereas those expressing the pathogenic form of KIF2A frequently changed directions ( Fig. 3A and C) . Interneurons use a saltatory mode of migration consisting of nuclear displacements (nucleokinesis) and pauses (32) . During nucleokinesis, cells acquire a higher instantaneous speed. We thus, analysed in more detail the kinematics of these cells. As expected, KIF2A pathogenic variant decreased the frequency and amplitude of the nucleokinesis (Fig. 3D-F) . Conversely, interneurons overexpressing the wild type version of the protein moved faster by performing a higher number of nuclear translocations. Together, these data show that MCDrelated KIF2A variant delays interneuron migration.
Mutant KIF2A alters neural progenitor proliferation and cell cycle exit
In view of the high expression of KIF2A in proliferative zones of the developing cortex (Supplementary Material, Fig. S1 ) we investigated whether proliferation defects could contribute to the pathophysiology of KIF2A-related MCD. To explore this, we electroporated KIF2A constructs in E14.5 embryos and analysed the expression of PH3, Pax6 and Tbr2 in electroporated cells two days later. First, we focused on the regulation of progenitor proliferation and we observed that mutant KIF2A overexpression induced an increased proportion of VZ progenitors undergoing mitosis, reflected by a higher mitotic index (Fig. 4A) . We further estimated the balance between proliferative and neurogenic divisions of radial glia. Although the mutant did not affect the amount of apical progenitors (APs) (Pax6þ/Tbr2-), we observed an increased percentage of newborn intermediate progenitors (IPs) (Pax6þ/Tbr2þ) in the mutant condition, with a concomitant reduction of neurons (Pax6-/Tbr2-) in the VZ/SVZ (Fig. 4B ). This suggests a decreased generation of neurons in favor of the production of progenitors. We also examined the apical junctions of radial precursors, known to be involved in symmetric versus asymmetric divisions in these cells (33, 34) , and observed no apparent change in b-catenin distribution, indicating that apical junction integrity was not altered (Supplementary Material, Fig. S4 ). These data show that mutant KIF2A, but not the overexpression of the wild type protein, interferes with the process of neurogenesis by favoring the generation of progenitors at the expense of neurons.
To further study the basis of this increase in proliferative cells, we analysed the consequences of KIF2A variant on cell cycle regulation. To investigate this, the electroporation of the different constructs at E14.5 was followed by a pulse of EdU (5-ethynyl-2'-deoxyuridin, a thymidine analogue) one day after to label progenitors undergoing DNA replication. Brains were collected and stained for the proliferative marker Ki67 at E16.5. Although there were no significant differences in the percentage of electroporated cells undergoing S-phase (EdUþ), we observed a significantly larger population of Ki67þ cells in the mutant condition. This resulted from a reduced number of cells exiting the cell cycle in the pathogenic condition (Fig. 4C) . These results suggest that progenitors expressing the KIF2A variant remain longer as cycling progenitors. These proliferation defects are specific to the mutation and hence potentially relevant for the pathophysiology of MCD.
Mutant KIF2A alters mitotic spindle integrity and impairs mitotic progression
To better understand the cellular mechanisms underlying mitotic division impairments upon expression of mutant KIF2A, we used the available fibroblasts derived from a female subject bearing the heterozygous KIF2A p.His321Asp variant and that presented with frontal band heterotopia, posterior predominant pachygyria and microcephaly. We first investigated the distribution of KIF2A in metaphasis cells. As previously described (35) , KIF2A mainly localizes to spindle poles as seen by its colocalization with c-tubulin, and is present at the mitotic spindle (Fig. 5A) , while the mutated version of the protein is the whiskers the minimum and maximum. One-way ANOVA with Tukey's post hoc test used to compare conditions. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. mislocalized and predominantly accumulated at the spindle poles, surrounding this structure. We first sought to analyse spindle orientation during mitosis, which is generally known to regulate the balance between symmetric and asymmetric divisions and therefore cell fate, which could explain the increased pool of proliferative progenitors. However, no significant differences were observed between the control and mutant fibroblasts (Fig. 5B) and was further confirmed in in utero electroporated brains, as no differences were observed in the orientation of the cleavage plane during anaphase (Supplementary Material, Fig. S5 ). We then characterized the morphology of mitotic spindles in fibroblasts by measuring their length, which is the distance from spindle pole to spindle pole, and the spindle width, considered to be the distance between the upper and lower extremities of the mitotic spindle in the metaphase plate (Fig. 5B) . As shown by the quantifications, mutant fibroblasts displayed shorter spindles with a reduction in the spindle width. To sum up, mutant KIF2A is abnormally localized during mitosis and is associated with an alteration of mitotic spindle integrity. (F) Kymographs describing the saltatory behavior profile of interneurons electroporated with an empty vector, WT or mutated KIF2A. The dashed line represents the threshold for nuclear translocations. From data (B) to (E), the central line represents the median, the box limits the interquartile range, and the whiskers the minimum and maximum. *P < 0.05, **P < 0.01, ****P < 0.0001. Dots on top of bar graph represent individual data points for each condition. Error bars are mean þ/-s.e.m. One-way ANOVA with Dunnett's post hoc test used to compare conditions (n ¼ 3 embryonic brains for each condition). *P < 0.05, **P < 0.01, ***P < 0.001, ns: non significant.
To further investigate the functional consequences resulting from these morphological defects, we focused on mitotic progression. In order to assess this, we used HeLa cells which stably express Histone2B tagged with RFP, and perform time-lapse live imaging to study the dynamics of mitosis. Cells were either transfected with a control empty vector, the wild type or the mutant version of KIF2A, and were imaged for 12 h. Cells expressing the mutant KIF2A protein, exhibit a delay in mitotic progression, with a particular impact in metaphase alignment of chromosomes (Fig. 5C ). This delay in mitosis progression could therefore explain the increased percentage of in utero electroporated PH3þ cells in the mutant condition. 
Mutant KIF2A alters ciliogenesis in apical progenitors
It has been well established that KIF2A localizes to the basal body, where it acts as a negative regulator of ciliogenesis controlling axonemal MT disassembly (28) . On the other hand, defects in primary cilia structure and function have been associated to numerous genetic diseases with neurodevelopmental consequences (36) . We therefore analysed the localization of endogenous KIF2A on primary cilia in mutant fibroblasts. As previously described, we found that wild type KIF2A is enriched in the basal body as seen by its localization in the basal part of the primary cilia (Fig. 6A) . On the other hand, the mutant version of the protein is less accumulated in the basal body and dispersed within the primary cilia, as shown by its colocalization with acetylated-tubulin (Fig. 6A) .
Since KIF2A is abnormally localized in mutant fibroblasts, and its MT-depolymerizing activity at the basal body is essential for cilia disassembly in proliferating cells (28), we assessed the impact of KIF2A variant on ciliogenesis. For this, we analysed cilia number and morphology in fibroblasts derived from affected individuals 24h after serum stimulation. In order to assess specifically cilia disassembly, we focused on cells in S-G2 phase of cell cycle, which is when primary cilia are reabsorbed. Fig. S6B ). However, when we examined the length of cilia in restimulated fibroblasts in S/G2, we observed that the mutant fibroblasts had longer cilia than those in the control fibroblasts (Fig. 6B) . During cortical development, proper ciliogenesis is essential for the correct progression of cell cycle in APs. To further explore the in vivo consequences of KIF2A mutant on ciliogenesis and the potential implication in cortical development, cilia length and frequency were determined in APs of in utero electroporated brain slices. E14.5 embryos were electroporated with KIF2A constructs, BLBP-GFP and V5-tagged Arl13b. Coimmunostaining of brain at E15.5 for V5 and the S/G2 marker geminin in the ventricular zone revealed cilia alterations. In line with our cellular observations, the proportion of electroporated cells in S/G2 phase was not altered in vivo (Supplementary Material, Fig. S6C ). Furthermore, gemininþ neurons overexpressing mutant KIF2A have longer cilia compared with those electroporated with the empty vector or wild type construct ( Fig. 6C and D) . Additionally, we observed an increase of 20% in the percentage of ciliated APs in the mutant condition ( Fig. 6C  and E) , which strengthens the idea of a possible defect in the disassembly of cilia during these phases. However, the apparent absence of accumulation of electroported S/G2 APs was intriguing. As geminin marker does not allow to distinguish cells in G2 and S phases, we sought to assess the distribution with respect to the ventricular surface of ciliated gemininþ APs nuclei that had been electroporated. For this we divided the VZ in equalsized bins parallel to the ventricle and quantified the number of nuclei present in each bin. We observed that the dispersion of the nuclei was significantly different between mutant expressing cells than in those expressing either the WT form of KIF2A or the empty vector (Fig. 6F) . Indeed, the percentage of cells expressing the mutated form of the protein are clearly enriched in lower half of the VZ compared with the controls (Fig. 6G ) consistent with an enrichment of electroporated cells in G2-phase (37, 38) . Together, these findings suggest a defective regulation of ciliogenesis in APs during cortical development that could contribute to the pathophysiology of KIF2A-associated MCD.
Discussion
KIF2A is an MT-associated motor protein which has been well described for its MT-depolymerizing activity (18) . Currently, all of the identified variants in this gene associated to MCDs are located in or in close vicinity of the nucleotide binding pocket within the motor domain of the protein (Supplementary  Material, Fig. S2A ). Here, we performed a combination of in vivo and in cellulo studies, to better understand the pathophysiological mechanisms underlying MCD associated with p.His321Asp and p.Ser317Asn variants, thought to be different from KIF2A loss-of-function related cortical development defects previously reported in the mouse (25) . Indeed, Kif2a knock-out mice (kif2a-/-) are viable only until one day after birth, and presented multiple brain alterations including cortical lamination defects as a result of a faulty migration of newborn neurons, emphasizing the importance of KIF2A during brain development. In fact, KIF2A seems to be relatively intolerant to loss-of-function variants according to ExAC database (pLi ¼ 1) though the number of synonymous variations are similar to the expected, standing against a loss-of-function mechanism. Our work demonstrates that KIF2A pathogenic mutants are stable and lead to an abnormal localization of neurons within the deep layers of neocortex during development and that persists in the white matter after birth. Although the developmental phenotype observed due to the expression of the mutant protein resembles that of the downregulation (Figs 1 and 3, Supplementary Material, Fig. S7 ) and the knock-out animal model, the molecular mechanisms involved may be different. First, it is worth mentioning that most pathogenic variants identified so far in genes related to MCD correspond to heterozygous missense variants but not loss-of-function variants. Additionally, clinical data argue against an haploinsufficiency, as individuals with proximal 5q12 deletions that contain KIF2A presented neurocognitive defects but without any evidence of MCDs in the brain MRI (39) . Second, and consistent with a dominant negative effect, previous data showed that in heterozygous fibroblasts bearing KIF2A pathogenic variants, endogenous KIF2A is mainly mislocalized along microtubules (10, 16) . The present study expands this phenotype to migrating neurons overexpressing a KIF2A mutant. Given that KIF2A functions as a dimer (40), these observations suggest that in interphase mutant KIF2A could sequester the wild type protein to MTs, probably blocking its function. Altogether, these data indicate that MCD-related KIF2A mutants act through a potential dominant negative effect in dividing cells, post-mitotic migrating neurons and primary cilia, and could therefore disrupt neuronal processes during cortical development (Fig. 7) .
Here, we provide evidence showing that expression of mutant KIF2A leads to a mislocalization of pyramidal neurons, likely resulting from the combination of migration and proliferation defects. We found that mutant KIF2A engenders a locomotion defect in migrating projection neurons. Cytoskeleton remodeling is essential for this, as it ensures the dynamic cellshape changes required for the proper migration of pyramidal neurons during development (41) (42) (43) (44) . In line with this, the downregulation of the MT-associated proteins LIS1 and DCX, also known to be implicated in MCDs, have severe consequences in neuronal migration (45, 46) . More rarely studied, but nevertheless as important as projection neurons, are interneurons and their contributions in pathophysiological processes underlying MCD. In this study, we showed that KIF2A variants not only alter migration of pyramidal neurons, but also interneuron migration dynamics. During cortical development, interneurons migrate tangentially from the ganglionic eminences to reach their appropriate location in the cerebral cortex. We observed a reduction in migration velocity with defective nucleokinesis, all of this highly dependent on MT remodeling. This suggests a possible contribution of tangential migration in the pathogenesis of these MCDs.
Interestingly, we found that mutant KIF2A is associated with cell cycle defects (Fig. 7) . Indeed, we observe a higher mitotic index and an increase in the number of newborn intermediate progenitors. We then showed that this is not due to an increase in proliferation per se, but rather to a delay in cell cycle progression with a longer duration of mitosis that could be reflected by the higher percentage of PH3 positive cells observed in vivo. This idea is supported by several sets of data. First, our videomicroscopy analysis shows a delay in mitotic progression, as a result of a defect during chromosome alignment in metaphase. Indeed, it has been shown that KIF2A regulates mitotic spindle formation and disassembly and the consequences of KIF2A downregulation is consistent with our observations (20) . Second, the increased amount of progenitors seems not to be due to an imbalance between symmetric and asymmetric divisions. This process is known to regulate cell fate and highly depends on mitotic spindle orientation. However, we did not observe any alteration in spindle angle during mitosis in cultured cells or in vivo (Fig. 5B, Supplementary Material, Fig. S5 ), implying that the increase in the progenitor pool could be due to a prolonged cell cycle. Finally, there is a decrease in cell cycle exit in vivo, consistent with the proposed hypothesis. It is well established that the date of birth of neurons is crucial in defining their identity and positioning within the cerebral cortex (47) . The delay in cell cycle exit observed in the mutant condition could therefore modify the fate of newly formed neurons as well as influence their positioning in the cerebral cortex, which could contribute to the layering abnormalities observed in the pathology.
Our study also raises the possibility of an implication of primary cilia in the pathogenesis of the observed defects (Fig. 7) . Though the cause and effect concept between the convincing observed ciliogenesis abnormalities and progenitors proliferation deregulation remains to be further reinforced (mainly because KIF2A acts also as a regulator of MT dynamics at the mitotic spindle) our study clearly raises the possibility of an implication of primary cilia in the pathogenesis of the observed defects and therefore in the pathogenicity of KIF2A-related MCD. First, convergent evidence indicates that mutant KIF2A localization in primary cilia is disrupted. Instead of being enriched at the basal body, mutant KIF2A is predominantly distributed at the axoneme. Though MT disassembly occurs mainly at the ciliary tip, it has been clearly shown that the MTdepolymerizing activity of KIF2A at the basal body is essential for its role in ciliogenesis (28) . Moreover, in vivo and in cellulo data revealed that MCD-related KIF2A variant results in cilia reabsorption defects during S/G2 phases and an increased number of ciliated APs. Primary cilia are known to be dynamically regulated during cell cycle and seem to control the transition between different cell cycle phases (48) . Indeed, it has been suggested that the initiation of cilia disassembly during late G1 is necessary for the transition to S phase (49, 50) . Deregulations in cilia reabsorption seem to retain cells in G1 phase and as a result alter the balance between proliferation and differentiation of AP cells (50) . Yet, no study has ever assessed the role of G2 cilia disassembly prior to mitosis entry in neuronal progenitors. However, it is important to highlight that KIF2A MT-depolymerizing activity is enhanced through PLK1 phosphorylation, which is specifically expressed during S/G2 (28) . In view of these data, primary cilia disassembly defect and its dependent cell cycle deregulation could be seen as coherent consequences of mutant KIF2A expression if we take into account its depletion from the basal body and the fact that MCD-related variants act very likely through a dominant negative mechanism and affect therefore the distribution of wild type KIF2A.
So far, several studies have focused on the role of centrosome-related genes encoding for centrosomal proteins in the pathogeny of microcephaly (51) . Lately, it has been proposed that microcephaly could be described as a 'centriolopathy' (52) . However, a recent study highlighted that disruption of primary cilia dynamics, rather than centrosome biogenesis, could also contribute to the pathogenesis underlying microcephaly (53) . Moreover, it is worth mentioning that examination of primary cilia proteomics and the centrosome-cilium protein interaction landscape during ciliogenesis reveal the presence of most of the MCD-related genes, such as LIS1, TUBA1A, TUBB2B, DYNC1H1, KIF5C, TUBG1 and KIF2A (54-56). In conclusion, in view of the findings indicating that MCD-related KIF2A variants affect progenitors ciliogenesis and possibly the interplay between ciliogenesis and progenitors cell cycle, this strongly warrant widening investigations to assess whether mutations in other MCD-related genes are associated with primary cilia defects, and whether such defects, yet to be identified, contribute to better understand disrupted processes and pathophysiological mechanism underlying the heterogeneous group of MCD.
Materials and Methods
Western blot
Cells were lysed in RIPA buffer (Tris HCl 1M, pH 7.7; NaCl 5M; EDTA 0.5M; Triton X-100) supplemented with protease inhibitors (Roche) and phosphatase inhibitors (Sigma Aldrich). Protein concentration was measured using Bio-Rad protein assay reagent (Biorad Laboratories, CA). Samples were denatured at 95 C for 10 min in loading buffer then resolved in SDS-PAGE and transferred onto nitrocellulose membranes. Membranes were then blocked in 5% non-fat milk in TBS buffer, 0.1% Tween and then immunoblotted using anti-Kif2A (ab37005, rabbit, Abcam, 1: 10000), anti-Actin (mouse, IGBMC, 1: 1000) antibodies.
In utero electroporation
In utero electroporation was performed as described previously (10) using adult Swiss mice (Janvier). Animal experimentations were performed at the IGBMC animal facilities. The light/dark cycle for animals housed was 12h and all experiments were conducted during the light cycle. Timed pregnant mice (E14.5) were anesthetized with isoflurane (2 l per min of oxygen, 4% isoflurane during sleep and 2% isoflurane during surgery operation; Minerve). The uterine horns were exposed, and a lateral ventricle of each embryo was injected using pulled glass capillaries with Fast Green (2 mg/ml; Sigma) combined with 1 mg/ml of DNA constructs. Plasmids were further electroporated into the neuronal progenitors adjacent to the ventricle by discharging five electric pulses at 45V for 50 ms at 950 ms intervals using a CUY21EDIT electroporator (Sonidel Ltd). After electroporation, embryos were placed back in the abdominal cavity and development was allowed to continue until E16, E18 or P2. Embryos or pups brains were dissected and fixed in 4% PFA in PBS overnight.
Ex vivo electroporation of medial ganglionic eminence explants (MGE)
The heads of E13.5 NMRI embryos were harvested and the cortex removed in order to expose the ganglionic eminences. Plasmids to overexpress empty vector, wild type KIF2A, KIF2A mutants, control or Kif2A shRNA were used at a concentration of 1.5 mg/ml and were directly injected in the MGE. These plasmids were co-electroporated with a Tomato red plasmid used at a concentration of 0.5 mg/ml. Electroporation conditions: 50V, 5 pulses of 50ms duration spaced by 1s interval.
Culture of MGE explants
After electroporation, the MGE was microdissected from the embryo's heads and cut into pieces of approximately 1 mm 2 . These explants were placed on top of a cortical feeder layer prepared at least 24 h before. The feeder layer was prepared from homochronic cortices, dissociated and plated at high density (1-2Â10 6 cells on a 35 mm glass bottom dishes (MatTek Corporation) previously coated with poly-L-ornithine and laminin (SIGMA). The explants were maintained in culture in Neurobasal medium supplemented with B27 minus vitamin A (GIBCO) and penicillin/streptomycin. The feeders were maintained in at 37 C in humidified incubators with 5% CO 2 for at least 24h before time-lapse video recording.
Immunohistochemistry
Fixed mouse brains were placed in a solution of 4% low melting agarose (Bio-Rad) and cut in coronal sections (80 lm) using a vibrating blade microtome (Leica VT1000S, Leica Microsystems). Sections were blocked in PBS with 0.3% Triton-X100 and 2% of the appropriate serum at room temperature for 30 min. All primary antibodies were incubated overnight at 4 C with PBS, 0.3%
Triton-X100 and 2% of serum. 
EdU incorporation
For cell-cycle exit experiments, E14.5 electroporated pregnant mice were intraperitoneally injected 24h later with EdU (5-ethynyl-2'-deoxyuridine solution, Invitrogen) diluted in sterile normal saline at the dose of 40 mg EdU/kg of body weight and embryos were harvested and fixed at E16.5. EdU staining was conducted using Click-iT EdU Alexa Fluor 647 Imaging Kit (Invitrogen) according to manufacturer's protocol.
Expression constructs
Commercially available Human untagged KIF2A cDNA (NM_004520) cloned in pCMV6-XL5 vector (SC117315) were purchased from Origene. Variants (p.His321Asp and p.Ser317Asn) were introduced by site directed mutagenesis using QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies). WT and mutated cDNAs encoding human KIF2A were then inserted in the multiple cloning site of psiSTRIKE vector under the CAG promoter and between the DCX promoter and IRES-EGFP sequences in DCX-IRES-GFP vector kindly provided by U. Mueller (TSRI, CA, USA). BLBP-GFP plasmid was kindly provided by N. Heintz (The Rockefeller university, NY, USA). pDEST40-Arl13b11 expressing V5 tagged Arl13b was purchased from Addgene (#40873). For short hairpin Kif2a silencing constructs, a 29-mer sequence targeting the 3'UTR of the mouse Kif2a transcript and a HuSH 29-mer non-effective shRNA scrambled cassette, both commercially designed and provided by Origene in the p-GFP-V-RS vector (TG505433), were then subcloned in the psiSTRIKE vector under the U6 promoter. Plasmid DNAs used in this study were prepared using the EndoFree plasmid purification kit (Macherey Nagel).
Cell culture, transfections and immunofluorescence
Control and mutant fibroblasts carrying the KIF2A pHis321Asp variant were maintained in DMEM supplemented with 10% foetal bovine serum at 37 C. Cos-7 and mouse neuroblastoma N2A cell lines were cultured in DMEM supplemented with 5% foetal bovine serum and gentamicin (40 mg/ml) at 37 C. HeLa cells stably expressing H2B-RFP were grown in DMEM supplemented with 10% foetal bovine serum, 2 mM Glutamine, 0.5mg/ml of G418 and puromycin at 0.5 mg/ml. All the cell lines were not listed in database of commonly misidentified cell lines maintained by ICLAC. Cell lines have been tested for mycoplasma but not authenticated. Transfection of plasmids was done using Lipofectamine 2000 (Life Technologies) following manufacturer's instructions. For cilia analysis, fibroblasts at 70% confluence were serum starved for 24 h before fixation. Immunofluorescence images were performed by fixing cells with 4% paraformaldehyde solution for 20 min. Slides were blocked by a 30 min incubation with 0.3% Triton-X100 and 2% of the appropriate serum in PBS. Primary antibodies were incubated overnight in blocking solution in the following concentrations: acetylated-tubulin (32-2700, mouse, 1: 500, Thermofisher), a-tubulin (ab6160, rat, 1: 1000, Abcam), c-tubulin (T6557, mouse, 1: 500, Sigma Aldrich), tyrosinated tubulin (ab6160, rat, 1: 1000, abcam). Following, slides were incubated with the corresponding Alexa Fluor conjugated secondary antibodies (Life Technologies) in a 1: 500 dilution in 1X PBS for 30 min at room temperature. Slides were mounted with a Dapi containing Fluoromount-G mounting medium (Interchim). Images were acquired using TCS SP8 or a TCS SP5 II confocal microscopes (Leica Microsystems).
Videomicroscopy
For mitotic progression studies, HeLa cells stably expressing H2B-RFP, were cultured in 35 mm diameter bottom glass petridishes (MatTek). 48h after transfection, mitosis progression was imaged using a TCS SP8 confocal microscope kept at 37 C with 5% CO 2 . Acquisitions were every 3 min for 12 h. For slice culture, E16 brains from E14 DCX-empty vector or DCX-KIF2A-WT or DCX-KIF2A p.His321Asp electroporated embryos from Swiss mice, were embedded in 3% low-melt agarose (BioRad) diluted in HBSS (Hank's Balanced Salt Solution, ThermoFisher Scientific) and sliced (300 lm) with a vibratome (Leica VT1000S, Leica Microsystems). Brain slices were cultured 16 to 24 h in semi-dry conditions (Millicell inserts, Merck Millipore), in a humidified incubator at 37 C in a 5% CO 2 atmosphere in wells containing Neurobasal medium supplemented with 2% B27, 1% N2, and 1% penicillin/streptomycin (Gibco, Life Technologies). Slice cultures were placed in a humidified and thermoregulated chamber maintained at 37 C on the stage of an inverted confocal microscope. Time-lapse confocal microscopy was performed with a Leica SP8 scanning confocal microscope. Images were taken with a 25X objective and 25 successive 'z' optical plans spanning 50 lm every 30 min during 10 h. Sequences were analysed using Image J.
Spindle parameters assays
To increase the proportion of cells in mitosis, fibroblasts were synchronized by incubating cells with 9 lM RO-3306 (Roche) for 18 h. Cells were released from inhibition by incubating with fresh media for 35 min before fixation. Spindle parameters were calculated using ImageJ. The spindle angle was considered to be the one formed by between pole-pole axis and the substratum plane. Spindle length was measured as the distance between the two spindle poles. Spindle width is the distance between the upper and lower extremities of the mitotic spindle in the metaphase plate.
Statistics
All statistics were calculated with GraphPad Prism 6 (GraphPad Software). One-way ANOVA was performed for multiple comparisons (Empty vector, KIF2A WT, KIF2A p.His321Asp and KIF2A p.Ser317Asn) followed by the appropriate post hoc tests, whereas unpaired two-tailed Student's t-test was used for dual comparisons (Scramble vs. sh-KIF2A). P< 0.05 was considered significant with *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001. All the statistical tests were two-sided. No statistical methods were used to predetermine sample sizes but sample sizes were estimated on the basis of previous experiments in the laboratory and are similar to those generally employed in the field. After histological examination, only brains with comparative electroporated regions and efficiencies were conserved for quantification. For cellular experiments no data points were excluded and all data collected from each individual experiment was used for the analysis. No randomization procedure was applied in this study. Data distribution was not tested but assumed to be normal. The investigator was not blinded for data collection and analysis. All the statistical details are reported in supplemental material.
Study approval
The 
Supplementary Material
Supplementary Material is available at HMG online.
complementary studies involving the cellular consequences of KIF2A variants.
